Drug class
Ophthalmic Adrenergic Agents
Ophthalmic adrenergic agents are a therapeutic class of topical ocular medications that modulate adrenergic receptors—primarily through alpha-adrenergic receptor agonism (such as brimonidine or apraclonidine) or beta-adrenergic receptor blockade (such as timolol). Read more about Ophthalmic Adrenergic Agents
15 drugs in this class 14 manufacturers
Drugs in Ophthalmic Adrenergic Agents
UPNEEQ (PF) (oxymetazoline HCl/PF)
BRIMONIDINE TARTRATE-TIMOLOL (brimonidine tartrate/timolol maleate)
BRIMONIDINE TARTRATE-TIMOLOL (brimonidine tartrate/timolol maleate)
BRIMONIDINE TARTRATE-TIMOLOL (brimonidine tartrate/timolol maleate)
BRIMONIDINE TARTRATE-TIMOLOL (brimonidine tartrate/timolol maleate)
BRIMONIDINE TARTRATE-TIMOLOL (brimonidine tartrate/timolol maleate)
BRIMONIDINE TARTRATE-TIMOLOL (brimonidine tartrate/timolol maleate)
BRIMONIDINE TARTRATE-TIMOLOL (brimonidine tartrate/timolol maleate)
Ophthalmic adrenergic agents are a therapeutic class of topical ocular medications that modulate adrenergic receptors—primarily through alpha-adrenergic receptor agonism (such as brimonidine or apraclonidine) or beta-adrenergic receptor blockade (such as timolol).
Their principal mechanism of action involves decreasing the production of aqueous humor in the ciliary body and, for certain alpha-agonists, enhancing uveoscleral outflow or inducing local vasoconstriction.
Clinically, these agents are primarily indicated for reducing intraocular pressure in the management of open-angle glaucoma and ocular hypertension, as well as for perioperative pressure spike prevention, pupil dilation, or ocular redness relief.
-
fda.gov
Ophthalmic adrenergic agents are a therapeutic class of topical ocular medications that modulate adrenergic receptors—primarily through alpha-adrenergic receptor agonism (such as brimonidine or apraclonidine) or beta-adrenergic receptor blockade (such as timolol) Their principal mechanism of action involves decreasing the production of aqueous humor in the ciliary body and, for certain alpha-agonists, enhancing uveoscleral outflow or inducing local vasoconstriction Clinically, these agents are p...
-
fda.gov
Ophthalmic adrenergic agents are a therapeutic class of topical ocular medications that modulate adrenergic receptors—primarily through alpha-adrenergic receptor agonism (such as brimonidine or apraclonidine) or beta-adrenergic receptor blockade (such as timolol)
-
medpagetoday.com
Ophthalmic adrenergic agents are a therapeutic class of topical ocular medications that modulate adrenergic receptors—primarily through alpha-adrenergic receptor agonism (such as brimonidine or apraclonidine) or beta-adrenergic receptor blockade (such as timolol) Their principal mechanism of action involves decreasing the production of aqueous humor in the ciliary body and, for certain alpha-agonists, enhancing uveoscleral outflow or inducing local vasoconstriction Clinically, these agents are p...
-
nih.gov
Ophthalmic adrenergic agents are a therapeutic class of topical ocular medications that modulate adrenergic receptors—primarily through alpha-adrenergic receptor agonism (such as brimonidine or apraclonidine) or beta-adrenergic receptor blockade (such as timolol)
-
nih.gov
Ophthalmic adrenergic agents are a therapeutic class of topical ocular medications that modulate adrenergic receptors—primarily through alpha-adrenergic receptor agonism (such as brimonidine or apraclonidine) or beta-adrenergic receptor blockade (such as timolol) Their principal mechanism of action involves decreasing the production of aqueous humor in the ciliary body and, for certain alpha-agonists, enhancing uveoscleral outflow or inducing local vasoconstriction Clinically, these agents are p...
-
nih.gov
Their principal mechanism of action involves decreasing the production of aqueous humor in the ciliary body and, for certain alpha-agonists, enhancing uveoscleral outflow or inducing local vasoconstriction
-
nih.gov
Their principal mechanism of action involves decreasing the production of aqueous humor in the ciliary body and, for certain alpha-agonists, enhancing uveoscleral outflow or inducing local vasoconstriction
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.